Načítá se...
Sitagliptin and heart failure hospitalization in patients with type 2 diabetes
This study evaluated the risk of heart failure hospitalization in a 1:1 matched pair sample of sitagliptin ever and never users derived from the Taiwan's National Health Insurance. A total of 85,859 ever users and 85,859 never users matched on 8 digits of propensity score were followed for the...
Uloženo v:
| Vydáno v: | Oncotarget |
|---|---|
| Hlavní autor: | |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Impact Journals LLC
2016
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5308758/ https://ncbi.nlm.nih.gov/pubmed/27409676 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.10507 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|